Neuroproprioceptive Facilitation and Inhibition Physical Therapy Activates Adaptive and Plastic Changes in the Central Nervous System

CompletedNot a drug-phase studyMS (type not specified)NCT04355663

What it found

Results posted, not judged

Results are posted in the registry, but without a statistical test of the main measure. See the numbers below.

What was tested

Treatment tested

  • Motor program activating therapy
  • Vojta's reflex locomotion
  • Functional electric stimulation

Results by group

White Matter Integrity

2 months

GroupValueIntervalNumber analysed
Motor Program Activating Therapy0.5023 score on a scale0.0293 (Standard Deviation)42
Vojta's Reflex Locomotion0.5168 score on a scale0.0266 (Standard Deviation)29
Functional Electric Stimulation0.4747 score on a scale0.0293 (Standard Deviation)21

Motor Program Activating Therapy

0.5023

Vojta's Reflex Locomotion

0.5168

Functional Electric Stimulation

0.4747

Values as posted on ClinicalTrials.gov. Outcomes measured differently across trials are not directly comparable.

Safety

GroupParticipants at riskSerious adverse eventsDeaths
Vojta's Reflex Locomotion290 (0.0%)0
Motor Program Activating Therapy420 (0.0%)0
Functional Electric Stimulation211 (4.8%)0

As posted on ClinicalTrials.gov. Serious adverse events include any serious health event during the trial, whether or not the treatment caused it.

What it measured

Main measures

  • White Matter Integrity

    2 months

    MRI lesions

Other measures (4)

  • Berg Balance Scale, BBS

    2 months

    Walking and mobility
  • Timed up and go Test, TUG

    2 months

    Walking and mobility
  • the 12-item Multiple Sclerosis Walking Scale, MSWS - 12

    2 months

    Walking and mobility
  • the 29-item Multiple Sclerosis Impact Scale, MSIS -29

    2 months

    Quality of life (reported by participants)

Who could take part

MS (type not specified) · 18 to 70

Show the full criteria

Inclusion criteria

* prevailed spastic paraparesis, stable clinical status and treatment in the preceding 3 months determined by neurologist, * Expanded Disability Status Scale score (EDSS) max. 7.5

Exclusion criteria

* other neurological disease or conditions disabling movement

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

This study investigates whether neuroproprioceptive "facilitation, inhibition" physical therapy induces plastic and adaptive processes of the CNS (white matter integrity changes), if they relate to clinical improvement, and whether therapeutic effect differs between different kinds of therapies.

Papers

Loading reviews and guidelines…

History

    1. Started

      May 2015

    2. Main results due

      May 2017

    3. Finished

      Aug 2019

    4. Results posted

      Jul 2020

    Assembled by software from public sources.